Index

ABCl 73 apoptotic DNA ladder 7 acquired immunodeficiency syndrome (AIDS) arachidonic acid (AA) 19 73 aurin tricarboxylic acid 9 acute tubular necrosis 227,229 autoimmune disease 13 aggrecanase 166 autoimmune hemolytic amenia 47 anemia of chronic diseases (ACD) 92 autoreactive T cell 10 angiogenesis 232 anoikis 131 B cell, regulation of 47 anti-apoptotic drug 173 B1 integrin 124 antibody dependent cellular cytotoxicity B1 integrin (CD29) receptor 124 (ADCC) 135 BAD 12 anti-phospholipid autoantibody 73 basement membrane 121 anti-SSNRo antibody 137 Bax 134,170,229 Apaf-l 9 bcl-2 11-13, 128, 129, 134, 138, 154, 170, aplastic anemia 93 216,228-231,233 7, 19,213,227,228 bcl-2 family members, phosphorylation status of apoptosis, cell survival p35 blocked 12 174 bcl-x 128, 129 a poptosis, characteristics of bcl-XL 12 apoptosis, constitutive 57 bone morphogenetic protein (BMP) 173 apoptosis, defense against 126 bystander lysis 42 apoptosis, Fas dependent 41 apoptosis, inadequate 151 Caenorhabditis elegans 9 apoptosis, in physiology and disease 3 calcipotriene 222 apoptosis, reduced 153 calcium-dependent nuclease 9 apoptosis, regulation of 2 camptothecin 167 apoptosis, TNF dependent 44 cancer 13 apoptosis, ultraviolet radiation (UVR)-induced cartilage 163 126 cartilage degradation 164 apoptosis of erythroid progenitors 92 caspase 9, 11, 13,44,227-230 apoptotic body 7, 111 caspase-3 9, 166

239 Index

caspase-10 12 104 caspase-activated DNase (CAD) 70 defense against apoptosis 126 CDllb -/- mouse 66 desquamin 132 CD14 73 dexamethasone 8, 9 CD27 156 diadenosine polyphosphate 72 CD36 63 DNA degradation, internucleosomal 10 CD40 48 DNA fragmentation factor (DFF) 9 CD40L 47 DNA laddering 228 CD44 74 CD45 11 endochondral bone formation 164 CD69 69 endochondral ossification 107 CD70 156 eosinophil 56,57, 91 ced-3 9 eosinophil deletion by apoptosis 59 cell proliferation 19 eosinophil development 91 CEM human leukemia cell 8 eosinophil granulocyte 56 c-fos 154 epidermal differentiation 130 chemokine 61 epidermal growth factor receptor (EGFR) 123, chondrocyte apoptosis 164 216 chronic granulomatous disease 66 epidermis 121,218 clusterin 230 epithelial cell 227 c-myc 8, 154, 228, 229 Erythema multiforme 137 colony forming units-erythroid (CFU-E) 92 (EPO) 86, 92 colony forming units-megakaryocyte (CFU-MK) extracellular matrix (ECM) 72, 131 93 congenital CD18 deficiency 66 FADD 10 cpk mouse 228 Fas 8,9,48,68,129,166,220,231 CTLA4 46 Fas (CD95, Apo-1) 10 cyclic AMP 74 Fas activation 133 cycloheximide 128, 132 Fas antigen 104 cyclosporin A 220 68, 220 cytochrome C 9, 12 Fas ligation 68 cytokine 87, 135 Fas molecule ligand FasL 152 cytokine network 85, 89 227 cytoplasmic acidification 70 Fas/Fas ligand 40, 91 cytoplasmic tyrosine kinase 71 FasITNF family 46 cytotoxicity, immunologic 135 FasL 47,136 FasL gene transfer 157 Darier's disease 138 FGF signaling pathway 124 dATP 9 FGFR3 129 death domain 10, 12 fibroblast-like synoviocyte (FLS) 149 death program, constitutive 69 a4~1 fibronectin receptor 72 104 FLICE 10

240 Index

FLIP (Casper) 12 hematopoietic factor, inhibitory 86 Fos-LacZ transgenic mouse 171 hematopoietic growth factor 85 hematopoietic trophic factor 87 gelatinase-B (MMP-9) 166 hemolytic anemia 46 gene expression 8 host-reactive immune cell 7 glomerulonephritis 230, 231 human immunodeficiency virus (HIV) 227,232, glomerulosclerosis 227,230,232,233 233 glucocorticoid 8, 12, 74, 222 hyaluronan 103 glucocorticoid receptor (GR) 8, 11 hyaluronic acid (HA) 103 glucocorticoid steroid 58 hypertrophic chondrocyte 164 graft versus host disease (GVHD) 136 hypertrophic phenotype 165 granule exocytosis model 40 granulocyte 53 IgA nephropathy 231 granulocyte colony-stimulating factor (G-CSF) IgG Fc receptor (FcyR)-mediated apoptotic 86,92 pathway of eosinophil 91 granulocyte colony-stimulating factor (G-CSF), immune activation 135 maintaining viability 90 inflammation 53 granulocyte colony-stimulating factor (G-CSF), inflammation, apoptosis in resolution 58 supporting the growth of colony forming inflammatory arthritis 55 units-megakaryocyte (CFU-MK) 93 inflammatory bowel disease 47 granulocyte death 53 inflammatory cytokine 87,90 granulocyte lifespan 53 inflammatory disease 13 granulocyte-macrophage colony-stimulating inositol 1,4,5-triphosphate receptor (IP3Rl) 9 factor (GM-CSF) 86,91 insulin-like growth factor binding protein-3 217 granulocyte-macrophage colony-stimulating integrin 217 factor (GM-CSF), autocrine production of ~2 integrin 66 91 interferon aJ~ (IFNaJ~), enhancing apoptosis 90 granulocyte-macrophage colony-stimulating interferon y (IFNy) 91 factor (GM-CSF), inhibiting apoptosis 90 interferon y (IFNy), enhancing apoptosis 90 granulocyte-macrophage colony-stimulating interferon y (IFNy), inhibitory activity on factor (GM-CSF), maintaining viability 90 CFU-E 92 granulocyte-macrophage colony stimulating interferon y (IFNy), inhibitory effects of 90 factor (GM-CSF), supporting the growth of interferon regulatory factor (IRF-1) 11 colony forming units-megakaryocyte (CFU• interleukin-1 (IL-1) 91,92, 166 MK) 93 interleukin-l (IL-1), inhibitory activity on granzyme B 136, 152, 153 CFU-E 92 growth plate 105 interleukin-l (IL-l), inhibitory effects of 90 growth plate, developing 165 interleukin-l (IL-1), maintaining viability 90 interleukin-2 (IL-2) 11,47 hair follicle 122, 138 interleukin-2 (IL-2), inhibitory effects of 90 hematopoietic cell, expansion 85 interleukin-3 (IL-3) 86, 91, 92 hematopoietic cell, turnover 85 interleukin-3 (IL-3), inhibiting apoptosis 90

241 Index

interleukin-4 (IL-4) 11, 12 Iymphoproliferation (lpr) mouse 10 interleukin-4 (IL-4), inhibiting apoptosis 90 Iymphoproliferative syndrome 47 interleukin-4 (IL-4), inhibitory effects of 90 interleukin-5 (IL-5) 86, 91 macrophage 149 interleukin-5 (IL-5), autocrine production 91 macrophage, human monocyte derived 55 interleukin-5 (IL-5), inhibiting apoptosis 90 macrophage, inflammatory 55 interleukin-6 (IL-6) 92,93,218 macrophage, production of 91 interleukin-6 (IL-6), maintaining viability 90 macrophage, responses to uptake of apoptotic interleukin-7 (IL-7) 11,219 granulocytes 61 interleukin-9 (IL-9) 12 macrophage colony-stimulating factor (M-CSF) interleukin-10 (IL-10) 69 86 interleukin-15 (IL-15) 154 matrix metalloproteinase (MMP) 166 intracellular calcium 8, 9, 11 matrix metalloproteinase (MMP) inhibitors to involucrin 132 block matrix degradation 173 ionizing radiation 9 matrix metalloproteinase (MMP) stromelysin-1 ischemia 227,230 171 mcl-1 128 jck mouse 229 melanocyte 121, 135 joint fluid 55 membrane attack complex (MAC) 135 Jun NHz terminal kinase (JNK) 45 mesangial cell 227,231 Jurkat cell 9 MIP-1a 90 mitochondrial membrane potential 7 keratinocyte 213 mitochondrium 106, 107 keratinocyte apoptosis 122 mitosis 11 keratinocyte differentiation 123 multiple sclerosis (MS) 42 kidney 227, 229, 232, 233 myeloperoxidase (MPO) 59 kidney development 227 myelopoiesis 90 Kit ligand (KL) 86, 92 Kit ligand (KL), maintaining viability 90 necrosis 7 nerve growth factor (NGF) 129 laminin B1 9 neutrophil 57, 222 Lagerhans cell 122, 135 neutrophil, caspase-3 70 late apoptotic cell 64 neutrophil, circulation half life 54 late-stage (mature) anti-apoptotic therapy 174 neutrophil apoptosis, loss of injurious properties lectin 73 58 Lichen planus 136 neutrophil apoptosis, shedding of cell surface therapy 218 receptors 59 lupus nephritis 231 nitric oxide (NO) 9,68, 105, 152, 166 lymphocyte 218 non-steroidal anti-inflammatory drug (NSAID) lymphocyte, activity 7 173 lymphocyte, development 7 nuclease 13 lymphocyte, selection 7 nuclear factor KB (NFKB) 45

242 Index

oncosuppressor gene 154 PThrP 170 osteoarthritis (OA) 110, 163 pyrophosphate (PPi) 108 overlapping function 87 ras 154 oxidative stress 66 rat thymocyte 8 oxygen radical 152 reactive oxygen species 66, 135 redundancy 87 p53 133,134,154,217,228,229 Reiter's cell 55 p53 mutation 154 renal disease 227 p56lck 11 retinoid 220 p57kip2 170 retro-retinoid (RR) 221 pathogenesis 149 rheumatoid arthritis (RA) 46, 110, 149 pcy mouse 228 RU486 8 perforin 135 perforinfgranzyme mechanism of apoptosis S49 mouse lymphoma cell 8 40 scavenger receptor 73 phagocyte, semi-professional, fibroblast 64 self-ractive specificity 46 phagocyte, semi-professional, mesangial cell serine protease 135 64 serine/threonine protein phosphatase inhibitor phagocytosis of apoptotic neutrophils 61 okadaic acid 167 phosphatidyl serine 64 severe combined immunodeficiency (SCID) 11 phosphatidyl serine residue 7 spinous layer 121 phospholipase C (PLC) 11 sterol-regulatory element-binding protein photosensitive lupus 137 (SREBP) 9 pityriasis ruba pilaris 138 Stevens-Johnson syndrome 137 PKC inhibitor 12 stratum corneum 121 platelet 72 stromelysin-1 (MMP-3) 166 platelet production 93 subacute cutaneous lupus erythematosus (SCLE) polycystic kidney disease 227,228 137 poly ADP-ribose polymerase (PARP) 9 sunburn cell 126, 133 primary antiphospholipid antibody syndrome survival factor, granulocyte colony stimulating (PAPS) 74 factor (G-CSF) 57 proerythroblast 92 survival factor, granulocyte-macrophage colony pro-inflammatory cytokine 61 stimulating factor (GM-CSF) 57 protease cascade 9 survival factor, interleukin-5 (IL-5) 57 protein kinase C inhibitor staurosporine synovitis 153 167 synovium 149 protein synthesis inhibition 132 systemic lupus erythematosus (SLE) 46 proto-oncogene 154 systemic vasculitis 58 PS receptor 64 psoraten plus UVA (PUVA) 218 T cell 156,219 psoriasis 138,213 T cell, regulation of 46 PTHIPTHrP receptor 170 T cell receptor (TCR) 8, 10

243 Index

terminal differentiation 214 tumor necrosis factor a (TNFa) 67, 91, 92, ThIll 133,138,153,218,233 thapsigargin 8 tumor necrosis factor a (TNFa), enhancing thrombocystosis 93 a poptosis 90 (TPO) 86 tumor necrosis factor a (TNFa), inhibitory thrombopoietin (TPO), acting synergistically activity on CFU-E 92 with KL 93 tumor necrosis factor /3 (TNF/3) 92 thrombopoietin (TPO), suppressing apoptosis tumor necrosis factor /31 (TNF/31), enhancing of CD34+CD38- progenitors 93 apoptosis 90 thrombospondin 63 TUNEL-staining 32,228,229,231,233 thymus 8 type II collagen knockout mouse 168 transglutaminase 220 type II transglutaminase (TGase) promoter 169 transient amplifying cell (TAC) 215 tyrosine kinase 11 trophic hematopoietic factor 86 tumor growth factor /3 (TGF/3) 138 Ul associated 70 kDa protein 9 tumor growth factor /3 (TGF/3), diminishing the ultraviolet radiation (UVR) 126, 133 trophic effects of granulocyte-macrophage ultraviolet radiation (UVR)-induced apoptosis colony-stimulating factor (GM-CSF) 91 126 tumor growth factor /3 (TGF/3), diminishing the UVAI 133 trophic effects of interleukin-3 91 UVB 133,218 tumor growth factor /3 (TGF/3), diminishing the UVC 133 trophic effects of interleukin-5 91 tumor necrosis factor (TNF), inhibitory effects vasculitis 46 of 90 vitamin D 222 tumor necrosis factor (TNF) family of receptors av/33 vitronectin receptor 63 10 tumor necrosis factor (TNF)fTNFreceptor ZAP-70 11 (TNFR) 40, 129 zinc 10

244